EPHX2 and ulcer disease: In IL-10-deficient mice, limiting sEH activity decreased ulcers, tissue inflammation, and inflammatory cytokine expression (IFN-γ, TNF-α, MCP-1, VCAM-1), along with the downregulation of phosphorylated NF-κB.